IDXX
2025Q3BMOIDEXX Laboratories Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH
Street
Consensus EPS3.15
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move4.7%
IV front—
P/C full—
P/C front—
Features as of2025-10-31
Run-up
Close—
Ret 5d-1.8%
Ret 10d-0.9%
Ret 20d-0.3%
Ret 30d-4.1%
Actual EPS
3.40Beat
Estimated EPS3.15
Actual revenue
1.1B
Surprise %+7.9%
Beat / missBeat
Beat streak 44
Beat streak 88
Reaction
1-day stock reaction+4.3%
Implied vs actual
Implied 4.7%Actual 10.1%
Gap reaction+10.1%
Day result+14.8%
Next-day upYes
Realized / IV2.13×
Post tape
Post 5d-1.8%
Post 10d-7.5%
Post volume1.7M
Vol ×10d3.45×
Vol ×20d3.84×
Post range6.2%